Abstract
Objectives
Recent studies have demonstrated an increase in the frequency of idiopathic central precocious puberty (CPP) during the severe acute respiratory syndrome coronavirus 2 (COVID-19) pandemic. We compared the demographic, anthropometric, and clinical characteristics of idiopathic CPP patients diagnosed during a one-year period of the COVID-19 pandemic with the characteristics of patients diagnosed during the same period in the previous three-years.
Methods
Demographic, clinical, anthropometric, and laboratory data of all patients diagnosed in our Pediatric Endocrinology clinic with idiopathic CPP during a one-year period of the COVID-19 pandemic (April 2020–March 2021) and a three-year period before the pandemic (April 2017–March 2020) were evaluated retrospectively.
Results
A total of 124 patients (124 girls, zero boys) diagnosed with idiopathic CPP were included in this study. Sixty-six patients in the three-year period before the COVID-19 pandemic (April 2017–March 2020) and 58 patients (46.8%) in the one-year period during the COVID-19 pandemic period (April 2020–March 2021) were diagnosed with idiopathic CPP.
Conclusions
This study’s findings suggest that the number of girls diagnosed with idiopathic CPP during the one-year study period during the pandemic was more than double that of any of the previous three-years.
Acknowledgments
We would like to thank the children and their parents who participated in this study.
-
Research funding: None declared.
-
Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.
-
Competing interests: Authors state no conflict of interest.
-
Informed consent: Informed consent was obtained from all individuals included in this study.
-
Ethical approval: The current study was approved by the local ethics committee in light of the Helsinki Declaration.
References
1. Verzani, M, Bizzarri, C, Chioma, L, Bottaro, G, Pedicelli, S, Cappa, M. Impact of COVID-19 pandemic lockdown on early onset of puberty: experience of an Italian tertiary center. Ital J Pediatr 2021;47:52. https://doi.org/10.1186/s13052-021-01015-6.Search in Google Scholar PubMed PubMed Central
2. Stagi, S, De Masi, S, Bencini, E, Losi, S, Paci, S, Parpagnoli, M, et al.. Increased incidence of precocious and accelerated puberty in females during and after the Italian lockdown for the coronavirus 2019 (COVID-19) pandemic. Ital J Pediatr 2020;46:165. https://doi.org/10.1186/s13052-020-00931-3.Search in Google Scholar PubMed PubMed Central
3. Carel, JC, Eugster, EA, Rogol, A, Ghizzoni, L, Palmert, MR, ESPE-LWPES GnRH Analogs Consensus Conference Group, et al.. Consensus statement on the use of gonadotropin-releasing hormone analogs in children. Pediatrics 2009;123:e752–62. https://doi.org/10.1542/peds.2008-1783.Search in Google Scholar PubMed
4. Brix, N, Ernst, A, Lauridsen, LLB, Parner, ET, Arah, OA, Olsen, J, et al.. Childhood overweight and obesity and timing of puberty in boys and girls: cohort and sibling-matched analyses. Int J Epidemiol 2020;49:834–44. https://doi.org/10.1093/ije/dyaa056.Search in Google Scholar PubMed PubMed Central
5. Boafo, A, Greenham, S, Alenezi, S, Robillard, R, Pajer, K, Tavakoli, P, et al.. Could long-term administration of melatonin to prepubertal children affect timing of puberty? A clinician’s perspective. Nat Sci Sleep 2019;11:1–10. https://doi.org/10.2147/nss.s181365.Search in Google Scholar
© 2021 Walter de Gruyter GmbH, Berlin/Boston
